BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mitusova K, Peltek OO, Karpov TE, Muslimov AR, Zyuzin MV, Timin AS. Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01610-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Miao YB, Zhao W, Renchi G, Gong Y, Shi Y. Customizing delivery nano-vehicles for precise brain tumor therapy. J Nanobiotechnology 2023;21:32. [PMID: 36707835 DOI: 10.1186/s12951-023-01775-9] [Reference Citation Analysis]
2 Dean PT, Hooks SB. Pleiotropic effects of the COX-2/PGE2 axis in the glioblastoma tumor microenvironment. Front Oncol 2023;12. [DOI: 10.3389/fonc.2022.1116014] [Reference Citation Analysis]
3 Obozina AS, Komedchikova EN, Kolesnikova OA, Iureva AM, Kovalenko VL, Zavalko FA, Rozhnikova TV, Tereshina ED, Mochalova EN, Shipunova VO. Genetically Encoded Self-Assembling Protein Nanoparticles for the Targeted Delivery In Vitro and In Vivo. Pharmaceutics 2023;15. [PMID: 36678860 DOI: 10.3390/pharmaceutics15010231] [Reference Citation Analysis]
4 Semyachkina-Glushkovskaya O, Terskov A, Khorovodov A, Telnova V, Blokhina I, Saranceva E, Kurths J. Photodynamic Opening of the Blood-Brain Barrier and the Meningeal Lymphatic System: The New Niche in Immunotherapy for Brain Tumors. Pharmaceutics 2022;14. [PMID: 36559105 DOI: 10.3390/pharmaceutics14122612] [Reference Citation Analysis]
5 Hedna R, Kovacic H, Pagano A, Peyrot V, Robin M, Devred F, Breuzard G. Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma. Cancers 2022;14:5386. [DOI: 10.3390/cancers14215386] [Reference Citation Analysis]